Research brief · Growth Hormone
CJC-1295 with DAC
Long-acting GHRH analogue for sustained IGF-1 research models.
Class
Long-acting GHRH analogue
Half-life
~6–8 days
Studied in
Sustained IGF-1 elevation models.
What it is
The DAC (Drug Affinity Complex) modification covalently binds serum albumin, dramatically extending the GHRH analogue's half-life and producing sustained IGF-1 elevation in laboratory models.
Mechanism studied
Drug Affinity Complex binds albumin for sustained GHRH signaling.
Research notes
- Used where continuous GHRH tone is the research endpoint.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.